Born in the ’80s at the beginning of Seattle’s rock-music renaissance, the grunge aesthetic didn’t truly blossom until the early ’90s. But before it became a full-fledged fashion phenomena ...

Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...

The modernist aesthetic is now adapted to the demands ... First track “Matte Glaze” builds steadily to biting alto sax while “Motion” follows a similar but more expansive path with June ...

Strong cash position expected to fund Alto’s planned operations through multiple near-term milestones across pipeline of independent programs – MOUNTAIN VIEW, Calif., October 22, 2024 ...